Aeglea BioTherapeutics is based in Austin, Texas. It has raised $375M in total funding. Latest round: Growth. Backed by Fairmount Funds.
Aeglea BioTherapeutics funding overview
Aeglea BioTherapeutics is based in Austin, Texas. Aeglea BioTherapeutics has raised $375M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in November 2023. The round record for Aeglea BioTherapeutics runs through 2023; nothing later has been disclosed. Investors on record include Fairmount Funds.
Aeglea BioTherapeutics at a glance
Total raised
$375M
Latest round
Growth
Latest round date
November 2023
Headquarters
Austin, Texas
Notable investors
Fairmount Funds
Frequently asked about Aeglea BioTherapeutics funding
How much has Aeglea BioTherapeutics raised?
Aeglea BioTherapeutics has raised $375M in total disclosed funding across the rounds on record.
Who has invested in Aeglea BioTherapeutics?
Fairmount Funds are named among the investors backing Aeglea BioTherapeutics.
What was the latest Aeglea BioTherapeutics funding round?
The most recent disclosed round is a Growth, announced in November 2023.
Where is Aeglea BioTherapeutics based?
Aeglea BioTherapeutics is based in Austin, Texas.
When did Aeglea BioTherapeutics last raise?
The last disclosed Aeglea BioTherapeutics round closed in November 2023 at Growth.
Round data for Aeglea BioTherapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Austin and backer lists below.
